← Leaderboards
Joshua O Ojwang
Zymetx, Inc.
$1,055,665
Attributed
$1,055,665
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $71.9K · FY2008–09$100K$75K$50K$25K$0
'08
'09
Funding mix
By agency
NIH$1,055,665 · 5
By mechanism
R44$718,215 · 1
R43$199,660 · 2
P20$137,790 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antiviral Agents”
- Constance Ann Benson · University Of California, San Diego$209,152,068
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$120,325,769
- Judith S. Currier · University Of California Los Angeles$102,391,456
- Beth Baseler · Leidos Biomedical Research, Inc.$83,440,795
- Sharon A Nachman · Johns Hopkins University$77,262,665
- John Damon Chodera · Sloan-Kettering Inst Can Research$58,660,403
Research focus
Antiviral AgentsDrug Design /Synthesis /ProductionDrug Screening /EvaluationMedicinal PlantsCell LineBiotechnologyDrug Discovery /IsolationRespiratory Syncytial VirusLaboratory MousePharmacokineticsProtein PurificationComplementChronicComplexEnvironmental Risk FactorFundingGenesChemical Structure FunctionCenters Of Research ExcellenceAutoimmune DiseasesFc ReceptorDietAllelesCandidate Disease Gene
Grant awards (6)
ROLE OF NULL GENE POLYMORPHISMS IN LUPUS GENETICS$65,919
P20 · FY2009 · RR · contact PI
ROLE OF NULL GENE POLYMORPHISMS IN LUPUS GENETICS$71,871
P20 · FY2008 · RR · contact PI
Ethnobotanical Anti-Respiratory Syncytial Virus Drugs$364,521
R44 · FY2003 · AI
Ethnobotanical Anti-Respiratory Syncytial Virus Drugs$353,694
R44 · FY2002 · AI
Development of Inhibitors Against HCV Infection$100,000
R43 · FY2002 · AI
ETHNOBOTANICAL BASED ANTI-RSV THERAPEUTICS$99,660
R43 · FY2000 · AI